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Marine organisms, in particular nudibranchs (Mollusca: 
nudibranchia), are known as a rich source of chemically diverse 
secondary metabolites exhibiting potential as antimalarial, anti-
inflammatory, antiviral and anticancer activity. We presented the 
chemical investigation of an extract of nudibranch Hypselodoris 
infucata collected from Bali, an unexplored water but rich in 
nudibranch diversity. The extract contained the known (–)-
furodysinin (1), a furanosesquiterpene that for the first time 
isolated from this species. Metabolite 1 was purified by 
chromatography and the structure was characterised by 
comparison of 1H NMR data with that of the reported data. The 
absolute configuration was determined by comparing the optical 
rotation values with the known enantiomer. In vitro cytotoxic 
activity of compound 1 against HeLa cell line displayed an IC50 at 
102.7µg/mL. We also report for the first time the development of 
a method to assay nudibranch extracts for their feeding 
deterrence activity against local shrimps Penaeus vannamei. The 
extract show food rejection with highly significant difference in 
respect to the control (P = 0.0061) at natural concentration of 
3.0mg/mL. 
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INTRODUCTION 
Secondary metabolites play an important 
role as a starting point in the drug discovery 
process. Marine organisms offer an abundant 
source of chemically diverse and biologically 
active secondary metabolites. Among marine 
organisms, sponges and nudibranchs are prolific 
sources of diverse natural products, and the 
study of their chemical properties has led to the 
discovery of many biologically potent chemicals 
with antimalarial, anti-inflammatory, antiviral 
and anticancer activity (Blunt et al., 2015). 
Nudibranchs (Mollusca: nudibranchia) 
are slow-moving marine molluscs with soft 
bodies and often present bright and attractive 
coloration. However, despite slow movements 
and the absence of physical attributes, only few 
predators have been documented. Chemoeco-
logical studies showed that nudibranchs may 
employ secondary metabolites as chemical 
defence mechanism against predators (Cimino 
and Ghiselin, 2009; Mudianta et al., 2014). The 
metabolites are either derived  from  their  diets  
mainly sponges or biosynthesized in de 
novo fashion (Fontana et al., 2012). This sponge-
prey relationship has resulted an array of 
metabolites with intriguing framework, which 
are not found in their terrestrial counterparts 
and showed the potential as new pharmaceutical 
agents (Gerwick and Moore, 2012). 
Furanosesquiterpenoids are the most 
dominant metabolites characterised from 
nudibranchs of the genus Hypselodoris 
(Gastropoda: nudibranchia) and they seem to 
be a specific chemotaxonomic marker in these 
organisms (Fontana et al., 2001). Additionally, 
some species within this genus have also been 
reported to produce diterpenoids (Hochlowski            
et al., 1982) as well as sesterpenoids (Cimino et 
al., 1993). There have been 17 different species 
of Hypselodoris chemically investigated and 
reported from 1982 until 2012. The animals 
were collected from disparate geographical 
regions including California (USA), Brazil (Latin 
America), the Mediterranean (Europe), South 
Africa, and India. 
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Here we presented an initial chemical 
investigation of nudibranch Hypselodoris infucata 
collected from Tulamben-Bali, a less-explored 
waters but rich in species diversity. Our 
research group have pioneered the chemical 
investigation of marine invertebrate mainly 
sponges and nudibranchs from this prolific site 
(Mándi et al., 2015; Mudianta et al., 2014). We 
also reported for the first time the development 
of a method to assay nudibranch extracts for 
their feeding deterrent activity against local 
shrimps Penaeus vannamei. 
 
MATERIAL AND METHIODS 
Materials 
Two specimens of Hypselodoris infucata 
(crawling length 2cm) were collected during 
fieldwork at Tulamben Bay, Bali in November 
2014. The specimens were identified by 
comparing the surface pictures with that in       
the encyclopaedia of nudibranch as well as       
with the online database such as nudipixel 
(www.nudipixel.net) and WoRM (www.marine-
species.org). The first specimen (coded by the 
authors as 28-11-14-12) was extracted for 
chemical study, while the second specimen 




Extraction and isolation of metabolite 
A single specimen of Hypselodoris infucata 
(Figure 1) was diced, extracted in acetone 
(3x10mL), and sonicated for 2min. The 
combined extracts were partitioned between 
water and dichloromethane (3x5mL) and 
subsequently the organic layer was dried with 
Na2SO4. Dried organic layer was evaporated to 
dryness to give a crude extract (5mg). The 
extract was passed through a normal-phase 
Sep-Pak cartridge eluting with 100% hexane 
(10mL) to provide compound 1 (1.3mg). 
 
General 
1H NMR data were recorded using 
Bruker Advance 500MHz spectrometers (5mm 
inverse probe, gradient selection). 
Measurements were made in deuterochloro-
form (CDCl3, referenced at: δH 7.26ppm, δC 
77.16ppm). Chemical shifts (δ) were recorded 
in parts per million (ppm) and coupling 
constants (J values) were measured in Hertz 
(Hz). Positive ion electrospray mass spectra 
were determined using a Bruker Esquire HCT 
instrument (LRESIMS) with MeOH as solvent. 
Infra-red spectrum was recorded on a 
PerkinElmer FT-IR/FIR spectrometer. Specific 
optical rotations were measured at the sodium 
D line (589nm) at ambient temperature using a 
1mL quartz cell with a 10cm path length, using 
a Jasco P-2000 polarimeter. TLC investigations 
were performed on TLC silica gel 60G F254 
(Merck). Solvents were distilled prior to use. 
GC/MS analyses were performed on a 
Shimadzu GCMS QP-2010 Plus gas 
chromatograph mass spectrometer, operating at 
70eV, fitted with a DB-5 column (30m, internal 
diameter 0.25mm, J&W Scientific). Standard 
GCMS programme: split mode; column flow 
1.5mL/min; initial oven temperature 100°C 
(isothermal for 3min), ramp 16°C/min to 
250°C held for 10min; injection temperature 
250°C (total programme time 30min). Samples 




In vitro anticancer assay of compound 1 
against HeLa tumor cell line was performed by 
colorimetric assay using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetra-zolium bromide (MTT) 
(Hughes and Mehmet, 2003). The HeLa 
cervical cancer cell lines were cultured in RPMI 
1640 medium containing 10% Fetal Bovine 
Serum (FBS), 0.5% fungizone and 2% 
Penicillin-Streptomycin. The HeLa cells were 
plated at 10,000 cells per well and incubated at 
37°C with 5% of CO2 flow for 24h. After that, 
tested compound and doxorubicin as positive 
control were tested in a single concentration of 
30µg/mL (dissolved in RPMI medium) for 24h. 
Each sample was tested in three replicates. The 
cell-growth medium was removed from each 
well before the extracts were plated into the 
wells containing HeLa cells attached. Three 
kinds of controls were made, i.e. control of 
tumor cells, control of medium (medium 
without tumor cells) and control of samples 
(samples without tumor cells). After 24h 
treatment of the tested compound, the solution 
was removed from each well. After that, 100µL 
of MTT reagent (500μg/mL) was added into 
each wells and incubated for 4h in CO2 
incubator until purple  precipitate  was visible. 
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As much as 100µL of sodium dodecyl sulphate 
(SDS) 10% was added into each well, and 
incubated at room temperature (±27°C) in the 
dark for 12h. After incubation, the absorbance 
of each well was measured by DYNEX micro-
plate reader at wavelength of 570nm. The 
percentage of cell death was calculated using 




Description: A = absorbance of tumor 
cell control, B = absorbance of the sample,        
C = absorbance of sample control, D = 
absorbance of medium control.  
The anticancer activity against HeLa was 
then tested in serial concentration of 12.5, 25, 
50, and 75μg/mL. The Inhibition Concentration 
50 (IC50) value was then calculated using 
MINITAB 16.0 probit analysis. 
 
Feeding Deterrence Assay 
The second specimen of Hypselodoris 
infucata (coded as 28-11-14-13) was extracted in 
the same manner as the first one to give 6 mg 
crude extract. The feeding assay was carried out 
according to protocol reported by Mollo et al. 
(2008) (Mollo et al., 2008). In this assay we 
employed local shrimps Penaeus vannamei instead 
of the marine generalist shrimp  
 
 




Figure 2. spaghetti-strand like making (a); red-colored shrimp pellet (b); shrimp assayin progress (c); 
and red spot in the digestive tube of the shrimp (d) 
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Palaemon elegans 
The replacement of the shrimp species 
in Mollo’s protocol was due to the availability 
of the shrimps in the local area in Bali. The rest 
of the protocol was performed exactly as 
described by Mollo et al. (2008). The crude 
nudibranch extract (1mg) was dissolved in 
0.5mL of acetone was added to a mixture 
composed of alginic acid (30mg), ground 
freeze-dried squid mantle (50mg), and purified 
sea sand (3 mg; granular size 0.1-0.3mm). Sand 
was included in the mixture to prevent the 
floating of the pellets on the surface of the 
water during the experiments. After 
evaporation of the solvent, one drop of food 
coloring and distilled water was added to 1-mL 
volume. Food coloring was added for an easy 
detection of the ingested food in the digestive 
tube of the shrimps. The mixture was stirred, 
loaded into a 5mL syringe, and extruded into a 
0.25M calcium chloride solution for 2min to 
harden (Figure 2a). The resulting spaghetti-like 
red strand was cut into 10-mm-long pellets 
(Figure 2b). Control foods were made in the 
same manner, with the addition of 0.5mL of 
acetone but without the purified metabolites. 
Shrimps (average size 30mm), obtained from 
shrimp breeding site in North Bali, and were 
kept in an aquarium for 1 week to get them 
accustomed to the daily proposed artificial 
food. After 3 days of total fasting, they were 
individually placed in 500mL beakers filled with 
300mL of sea water (Figure 2c). Control or 
treated pellets were presented to shrimps in 
series of 10 independent replicates. After 
30min, the presence of an evident red spot in 
the digestive tube of the shrimps was assumed 
as proof of acceptance and, conversely, its 
absence was the sign of a rejection response 
(Figure 2d). The significance of differences in 
the consumption of treated vs. control pellets 
were evaluated by two-tailed Fisher's exact test. 
P values <0.05 were considered statistically 
significant. 
 
RESULTS AND DISCUSSION 
The chemistry of Hypselodoris infucata 
Compound 1 (1.3mg) was isolated as a 
colorless oil ([α]D –51) and showed a single 
GCMS   peak   at m/z  216  (M+)  with a strong  
 
diagnostic base peak at m/z 122 (C8H8O) 
arising from a retro Diels-Alder reaction of the 
carbocyclic ring adjacent to the furan ring 
(Dunlop et al., 1982). The 1H NMR (CDCl3, 
500MHz) spectrum of 1 revealed the presence 
of diagnostic furan protons at δH 7.21 (1H, d, J 
= 1.7Hz, H-1) and δH 6.23 (1H, d, J = 1.7Hz, 
H-2) together with an olefinic proton at δH 5.61 
(1H, brs, H-10). There were also two geminal 
methyl groups resonated at δH 1.19 (3H, s, H-
15) and δH 1.18 (3H, s, H-14) along with a 
methyl attached to an on olefinic carbon at δH 
1.66 (3H, s, H-13). These 1H NMR data of 1 
were in close agreement with those of the 
synthetic sample of furodysinin reported by 
Vaillancourt et al. in 1991 (Figure 3) 




Figure 3. 1H NMR data comparison of 
compound 1 
 
The tricyclic furanosesquiterpene (+)-
furodysinin (2), ([α]D +64) was first reported by 
Wells et al. in 1978 from an Australian Dysidea 
herbacea (Kazlauskas et al., 1978) without relative 
stereochemical assignment detail. Guella et al. 
subsequently characterised its enantiomer (–)-
furodysinin ([α]D –47) (Guella et al., 1985) from 
a specimen of D. tupha collected from the 
Mediterranean. The absolute configuration of 2 
has been established as as 6R,11R when 
optically pure (–)-furodysinin ([α]D –54) was 
synthesised by Vaillancourt et al. from (+)-9-
bromocamphor in four steps (Vaillancourt et 
al., 1991). Recently, (–)-(6R,11R)-furodysinin (1) 
has been isolated from D. herbacea (Fiji) (Horton 
et al., 1990), from H. bayeri collected from Cuba 
(Fontana et al., 1994), and from H. jacksoni from 
South-East Queeensland, Australia. (–)-
Furodysinin isolated from H. infucata in the 
current study has consistently been associated 
with a 6R, 11R configuration, whereas the 
positive counterpart shows a 6S, 11S 
configuration (Table I).  
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(–)-Furodysinin (1): colorless oil (1.3mg); 
[α]D = ‒51 (c 0.25, CHCl3); lit. [α]D = ‒54 (c 
0.5, CHCl3); (Vaillancourt et al., 1991) 1H 
NMR (CDCl3, 500 MHz) δH 7.21 (1H, d, J = 
1.7 Hz, H-1), 6.23 (1H, d, J = 1.7 Hz, H-2), 
5.61 (1H, brs, H-10), 2.70 (2H, m, H-5), 2.03 
(2H, m, H-8), 1.66 (3H, s, H-13), 1.50 (1H, 
overlap, H-6), 1.20 (1H, m, H-7), 1.19 (3H, s, 
H-15), 1.18 (3H, s, H-14); 
 GCMS m/z 216 [M]+ (20), 201 (5), 145 
95), 122 (100), 107 (20), 91 (15), 79 (25), 65 (5), 
53 (5). 
In vitro anticancer assay of (–)-
furodysinin (1) determined by MTT method 
displayed inhibition at IC50 at 102.7µg/mL 
which was less potent compared to the positive 
control doxorubicin that showed a value of 
2.3µg/mL. This result strongly suggested to 
explore other bioassay target for compound 1 
including antibiotic as some furanosesqui-
terpene metabolites were reported to show 
promising bioactivity (Richou et al., 1989). The 
bioactivity of compound 1 has never been 
reported, however related derivative such as 
acetylthioxy-furodysinin lactone, a bioactive 
component of the marine sponge Dysidea, was 
reported to show as a potent LTB4 receptor 
partial agonist (Carte' et al., 1989). 
 
Feeding deterrence profile of the 
extract of Hypselodoris infucata 
The feeding deterrence assay of the 
extract of H. infucata was carried out by 
following a protocol that was first reported by 
Mollo et al. (2008) except for the use of shrimps 
Penaeus vannamei instead of Palaemon elegans 
(Mollo et al., 2008). Mollo employed the assay 
to assess palatability of brominated 
Table I. Summary of stereochemical variations and sources of furodysinin. 
 
Compound Configuration Source Collection sites 
 [α]D C-6 C-11   
1  
–47 R R D.tupha (Guella et al, 1985) Mediterranean 
–54 R R Synthetic (Vaillancourt et al, 1991) - 
–61 R R D. herbacea (Horton et al, 1990) Fiji 
–55 R R H. bayeri (Fontana et al, 1994) Cuba 
–51 R R H. jacksoni Australia 
2  
     
+64 - - Dysidea sp.(Kazlauskas et al, 1978) Australia 
+30 S S D. herbacea (Searle et al, 1994) Australia 
 
 
Table II. 1H NMR data comparison of 1 
 
C 
1 (experiment) 1 (literature) 
δH (ppm), mult., J (Hz)a δH (ppm), mult., J (Hz) b 
1 7.21, d, 1.7 7.21, d, 2.1 
2 6.23, d, 1.7 6.24, d, 2.1 
5 2.70, m 2.73, m 
6 1.5, m 1.54, bd 
7 1.20, m 1.32, m 
8 2.03, m 2.03, m 
10 5.61, brs 5.57, bs 
13 1.66, s 1.66, s 
14 1.18, s 1.18, s 
15 1.19, s 1.19, s 
 
aChemical shifts  (ppm) referenced to CHCl3 δH 7.24 (CDCl3, 500 MHz);  
bChemical shifts  (ppm) referenced to CHCl3 δH 7.24 (CDCl3, 300 MHz); 
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tetrahydropyran isolated from Hypselodoris 
cyanomarginata against the generalist shrimp P.  
elegans collected at the Mediterranean seas. The 
brominated metabolites at its natural 
volumetric concentration found to show a 2.3 
mg/mL food rejection with a highly significant 
difference in respect to the control (P = 
0.0001).  
da Cruz (2012) replicated the feeding 
deterrence assay assay toxicity in a nudibranch-
sponge predator–prey association  obtained at 
Portuguese coast (da Cruz et al., 2012). 
Palatability tests of the crude extract of the 
sponge Dysidea fragilis and the nudibranch 
Hypselodoris cantabrica  revealed a more effective 
deterrence in the nudibranch extracts because 
significant rejection rates were observed at 
lower concentrations than those necessary for 
the sponge extracts to have the same effect. 
The extract (Figure 4) show food 
rejection with highly significant difference in 
respect to the control (P = 0.0061) at natural 
concentration of 3.0mg/mL. This value is 
considered to be identical with that found by 
Mollo and presented additional palatability data 




Figure 4. Dose-response curves for palatability 
tests of the extract of Hypselodoris infucata. 
Ten Penaeus vannamei specimens were randomly 
chosen for each test (n = 10). The significance 
of differences in the consumption of treated vs. 
control pellets were evaluated by two-tailed 
Fisher's exact test. P values <0.05 were 
considered statistically significant. 
 
CONCLUSION 
Chemical investigation of the extract of 
Balinese nudibranch Hypselodoris infucata yielded 
the known (–)-furodysinin (1). The metabolite 
was for the first time reported from this species 
and exemplified additional furanosesquiterpene 
metabolite isolated from the nudibranch. In vitro 
cytotoxic activity of compound 1 against HeLa 
cell line displayed an IC50 at 102.7 µg/mL. We 
also succeeded in replicating the feeding 
deterrence assay of the extract of H. infucata 
using local shrimps Penaeus vannamei. 
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